Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone
Contraindications: Personal or family history of medullary thyroid carcinoma or in patients with Multiple Endocrine Neoplasia syndrome type 2
Efficacy and safety of oral semaglutide monotherapy vs placebo or liraglutide in Japanese T2D patients: PIONEER 9 trial
Your age, health, habits, and biology all shape the response
Of course, pharmacotherapy is not the sole solution for weight loss
Hypogonadotropic Hypogonadism For individuals with hypothalamic dysfunction, kisspeptin can restore GnRH pulsatility and may reactivate the entire reproductive axis